Long‐term therapy with NTBC and tyrosine‐restricted diet in a murine model of hereditary tyrosinemia type I

Methods of Enzymatic Analysis

(1975) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/58.5.1085 · Cited by 20,078 · see citing works

Methods of enzymatic analysis

(1985) · International Journal of Biochemistry · doi:10.1016/0020-711x(85)90098-9 · Cited by 3,497 · see citing works

Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase

LINDSTEDT, S. (1992) · The Lancet · doi:10.1016/0140-6736(92)92685-9 · Cited by 631 · see citing works

On the enzymic defects in hereditary tyrosinemia.

Lindblad, B., Lindstedt, S., & Steen, G. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.10.4641 · Cited by 447 · see citing works

Monogenic traits are not simple: lessons from phenylketonuria

Scriver, C. R., & Waters, P. J. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(99)01761-8 · Cited by 421 · see citing works

Phenotypes of Patients with “Simple” Mendelian Disorders Are Complex Traits: Thresholds, Modifiers, and Systems Dynamics

Dipple, K. M., & McCabe, E. R. B. (2000) · The American Journal of Human Genetics · doi:10.1086/302938 · Cited by 418 · see citing works

Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice

Grompe, M., al-Dhalimy, M., Finegold, M., Ou, C. N., Burlingame, T., Kennaway, N. G., & Soriano, P. (1993) · Genes & Development · doi:10.1101/gad.7.12a.2298 · Cited by 355 · see citing works

Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I

Grompe, M., Lindstedt, S., Al-Dhalimy, M., Kennaway, N. G., Papaconstantinou, J., Torres-Ramos, C. A., Ou, C.-N., & Finegold, M. (1995) · Nature Genetics · doi:10.1038/ng0895-453 · Cited by 312 · see citing works

Tyrosinaemia type I and NTBC (2‐(2‐nitro‐4‐trifluoromethylbenzoyl)‐1,3‐cyclohexanedione)

Holme, E., & Lindstedt, S. (1998) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005410820201 · Cited by 264 · see citing works

Modifier Genes Convert “Simple” Mendelian Disorders to Complex Traits

Dipple, K. M., & McCabe, E. R. B. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3052 · Cited by 248 · see citing works

NONTRANSPLANT TREATMENT OF TYROSINEMIA

Holme, E., & Lindstedt, S. (2000) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70142-2 · Cited by 159 · see citing works

The Mutagenicity of the Tyrosine Metabolite, Fumarylacetoacetate, Is Enhanced by Glutathione Depletion

Jorquera, R., & Tanguay, R. M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6220 · Cited by 119 · see citing works

Hereditary tyrosinemia type I--an overview.

Kvittingen, E. A. (1986) · PubMed · Cited by 109 · see citing works

Consequences of Complexity within Biological Networks: Robustness and Health, or Vulnerability and Disease

Dipple, K. M., Phelan, J. K., & McCabe, E. R. B. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3227 · Cited by 102 · see citing works

Visceral pathology of hereditary tyrosinemia type I.

Russo, P., & O’Regan, S. (1990) · PubMed · Cited by 97 · see citing works

Deficiency of an enzyme of tyrosine metabolism underlies altered gene expression in newborn liver of lethal albino mice.

Ruppert, S., Kelsey, G., Schedl, A., Schmid, E., Thies, E., & Schütz, G. (1992) · Genes & Development · doi:10.1101/gad.6.8.1430 · Cited by 95 · see citing works

Liver transplantation for tyrosinemia

Mieles, L., Esquivel, C. O., Thiel, D. H. V., Koneru, B., Makowka, L., Tzakis, A. G., & Starzl, T. E. (1990) · Digestive Diseases and Sciences · doi:10.1007/bf01537237 · Cited by 83 · see citing works

Complete Rescue of Lethal Albino c Mice by Null Mutation of 4-Hydroxyphenylpyruvate Dioxygenase and Induction of Apoptosis of Hepatocytes in These Mice by in VivoRetrieval of the Tyrosine Catabolic Pathway

Endo, F., Kubo, S., Awata, H., Kiwaki, K., Katoh, H., Kanegae, Y., Saito, I., Miyazaki, J., Yamamoto, T., Jakobs, C., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24426 · Cited by 63 · see citing works

Ionic calcium levels during pregnancy, at delivery and in the first hours of life

Martinez, M. E., Sanchez, C. F., Salinas, M., Pellegrini, J., Carrasco, A., Catalán, P., Balaguer, G., & Quero, J. (1986) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518609086477 · Cited by 55 · see citing works

Therapeutic trials in the murine model of hereditary tyrosinaemia type I: A progress report

Grompe, M., Overturf, K., Al-Dhalimy, M., & Finegold, M. J. (1998) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005462804271 · Cited by 54 · see citing works

In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I

Manning, K., Al-Dhalimy, M., Finegold, M. J., & Grompe, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11928 · Cited by 51 · see citing works

Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione (NTBC) and its effect on enzymes involved in tyrosine catabolism in the mouse

Lock, E. A., Gaskin, P., Ellis, M. K., Provan, W. M., Robinson, M., & Smith, L. L. (2000) · Toxicology · doi:10.1016/s0300-483x(99)00205-x · Cited by 33 · see citing works

Comparative utilization of a crystalline amino acid diet and a methionine-fortified casein diet by young rats and mice

Hirakawa, D. A., Olson, L. M., & Baker, D. H. (1984) · Nutrition Research · doi:10.1016/s0271-5317(84)80064-0 · Cited by 28 · see citing works

Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1

Bain, M. D., Purkiss, P., Jones, M. A., Bingham, P. J., Stacey, T. E., & CHALMERS, R. A. (1990) · European Journal of Pediatrics · doi:10.1007/bf02034752 · Cited by 12 · see citing works

Effect of dietary treatment on the renal tubular function in a patient with hereditary tyrosinemia.

Suzuki, Y., Konda, M. R., Imai, I., IMAMURA, H., Shimao, S., & Okaka, T. (1987) · PubMed · Cited by 10 · see citing works

Liver transplantation in type I tyrosinemia.

Pascual, F. J. M., Vázquez, J., Gámez, M., López Santamaría, M., de la Vega, A., Mc, D., Jara, P., & Tovar, J. A. (1995) · PubMed · Cited by 8 · see citing works

[Dietary management of hereditary tyrosinemia. Apropos of 7 cases].

Jehan, P., Buchman, M., & Odièvre, M. (1984) · PubMed · Cited by 4 · see citing works

Altered metabolite levels in cancer: implications for tumour biology and cancer therapy

Sullivan, L. B., Gui, D. Y., & Heiden, M. G. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.85 · Cited by 406 · see citing works

Kinetics of Liver Repopulation after Bone Marrow Transplantation

Wang, X., Montini, E., Al-Dhalimy, M., Lagasse, E., Finegold, M. J., & Grompe, M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64212-5 · Cited by 236 · see citing works

NTBC treatment in tyrosinaemia type I: Long‐term outcome in French patients

Masurel‐Paulet, A., Poggi‐Bach, J., Rolland, M. ‐., Bernard, O., Guffon, N., Dobbelaere, D., Sarles, J., de Baulny, H. O., & Touati, G. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0793-1 · Cited by 212 · see citing works

Nitisinone in the Treatment of Hereditary Tyrosinaemia Type 1

McKiernan, P. J. (2006) · Drugs · doi:10.2165/00003495-200666060-00002 · Cited by 151 · see citing works

Bipotent transitional liver progenitor cells contribute to liver regeneration

Pu, W., Zhu, H., Zhang, M., Pikiolek, M., Ercan, C., Li, J., Huang, X., Han, X., Zhang, Z., Lv, Z., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01335-9 · Cited by 138 · see citing works

Adeno‐associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo†‡

Paulk, N. K., Wursthorn, K., Wang, Z., Finegold, M. J., Kay, M. A., & Grompe, M. (2010) · Hepatology · doi:10.1002/hep.23481 · Cited by 135 · see citing works

Mice With Human Livers

Grompe, M., & Strom, S. C. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.09.009 · Cited by 133 · see citing works

In Vivo Correction of Murine Hereditary Tyrosinemia Type I by ϕC31 Integrase-Mediated Gene Delivery

Held, P. K., Olivares, E. C., Aguilar, C., Finegold, M. J., Calos, M. P., & Grompe, M. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.11.001 · Cited by 129 · see citing works

Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry: analysis of succinylacetone extracted from dried blood spots

Allard, P., Grenier, A., Korson, M. S., & Zytkovicz, T. H. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.07.006 · Cited by 99 · see citing works

The Degree of Liver Injury Determines the Role of P21 in Liver Regeneration And Hepatocarcinogenesis in Mice

Buitrago‐Molina, L. E., Marhenke, S., Longerich, T., Sharma, A. D., Boukouris, A. E., Geffers, R., Guigas, B., Manns, M. P., & Vogel, A. (2013) · Hepatology · doi:10.1002/hep.26412 · Cited by 92 · see citing works

Efficient production of Fah -null heterozygote pigs by chimeric adeno-associated virus-mediated gene knockout and somatic cell nuclear transfer

Hickey, R., Lillegard, J. B., Fisher, J. E., McKenzie, T. J., Hofherr, S. E., Finegold, M. J., Nyberg, S. L., & Grompe, M. (2011) · Hepatology · doi:10.1002/hep.24490 · Cited by 86 · see citing works

Neurocognitive outcome in patients with hypertyrosinemia type I after long‐term treatment with NTBC

Thimm, E., Richter‐Werkle, R., Kamp, G., Molke, B., Herebian, D., Klee, D., Mayatepek, E., & Spiekerkoetter, U. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9394-5 · Cited by 79 · see citing works

Herbicide safety relative to common targets in plants and mammals

Shaner, D. L. (2003) · Pest Management Science · doi:10.1002/ps.782 · Cited by 69 · see citing works

Early nitisinone treatment reduces the need for liver transplantation in children with tyrosinaemia type 1 and improves post‐transplant renal function

Bartlett, D. C., Lloyd, C., McKiernan, P. J., & Newsome, P. N. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9683-x · Cited by 69 · see citing works

Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death

Vogel, A., van den Berg, I. E. T., Al-Dhalimy, M., Groopman, J. D., Ou, C., Ryabinina, O. P., Iordanov, M. S., Finegold, M. J., & Grompe, M. (2004) · Hepatology · doi:10.1002/hep.20077 · Cited by 66 · see citing works

Low Therapeutic Threshold for Hepatocyte Replacement in Murine Phenylketonuria

Hamman, K. J., Clark, H., Montini, E., Al-Dhalimy, M., Grompe, M., Finegold, M. J., & Harding, C. O. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.025 · Cited by 65 · see citing works

Tyrosinemia type I treated by NTBC: How does AFP predict liver cancer?

Koelink, C., van Hasselt, P. M., van der Ploeg, A., van den Heuvel‐Eibrink, M. M., Wijburg, F. A., Bijleveld, C. M. A., & van Spronsen, F. J. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.07.009 · Cited by 65 · see citing works

Loss of p21 Permits Carcinogenesis from Chronically Damaged Liver and Kidney Epithelial Cells despite Unchecked Apoptosis

Willenbring, H., Sharma, A. D., Vogel, A., Lee, A. Y., Rothfuß, A., Wang, Z., Finegold, M. J., & Grompe, M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.004 · Cited by 61 · see citing works

Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1

van Ginkel, W. G., Rodenburg, I. L., Harding, C. O., Hollak, C. E. M., Heiner-Fokkema, M. R., & van Spronsen, F. J. (2019) · Pediatric Drugs · doi:10.1007/s40272-019-00364-4 · Cited by 58 · see citing works

Amino acid metabolism and autophagy in skeletal development and homeostasis

Suzuki, A., & Iwata, J. (2021) · Bone · doi:10.1016/j.bone.2021.115881 · Cited by 54 · see citing works

Liver transplantation for hereditary tyrosinemia type I: Analysis of the UNOS database

Arnon, R., Annunziato, R. A., Miloh, T., Wasserstein, M., Sogawa, H., Wilson, M., Suchy, F. J., & Kerkar, N. N. (2011) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2011.01497.x · Cited by 52 · see citing works

Herbicide and Pharmaceutical Relationships

Duke, S. O. (2010) · Weed Science · doi:10.1614/ws-09-102.1 · Cited by 43 · see citing works

Activation of nuclear factor E2‐related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development†

Marhenke, S., Lamlé, J., Buitrago‐Molina, L. E., Cañón, J. M. F., Geffers, R., Finegold, M. J., Sporn, M. B., Yamamoto, M. P., Manns, M. P., Grompe, M., et al. (2008) · Hepatology · doi:10.1002/hep.22391 · Cited by 37 · see citing works

Extensive changes in liver gene expression induced by Hereditary Tyrosinemia type I are not normalized by treatment with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC)

Luijerink, M., Jacobs, S. M. M., van Beurden, E. A. C. M., Koornneef, L. P., Klomp, L. W. J., Berger, R., & van den Berg, I. E. T. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00433-1 · Cited by 36 · see citing works

Neurological and Neuropsychological Problems in Tyrosinemia Type I Patients

van Ginkel, W. G., Jahja, R., Huijbregts, S. C. J., & van Spronsen, F. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55780-9_10 · Cited by 35 · see citing works

AAV-Mediated Gene Targeting Is Significantly Enhanced by Transient Inhibition of Nonhomologous End Joining or the Proteasome In Vivo

Paulk, N. K., Loza, L. I. M., Finegold, M. J., & Grompe, M. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.038 · Cited by 35 · see citing works

Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah−/− knockout mice model

Orejuela, D., Jorquera, R., Bergeron, A., Finegold, M. J., & Tanguay, R. M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.09.014 · Cited by 34 · see citing works

In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions

Nicolas, C. T., VanLith, C. J., Hickey, R., Du, Z., Hillin, L. G., Guthman, R. M., Cao, W. J., Haugo, B. J., Lillegard, A., Roy, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32576-7 · Cited by 28 · see citing works

Nitisinone: a review

Zeybek, A. Ç. A., & Zübarioğlu, T. (2017) · Orphan Drugs Research and Reviews · doi:10.2147/odrr.s92995 · Cited by 28 · see citing works

Pharmacological rescue of the 14CoS/14CoS mouse: hepatocyte apoptosis is likely caused by endogenous oxidative stress

Dieter, M. Z., Freshwater, S. L., Miller, M. L., Shertzer, H. G., Dalton, T. P., & Nebert, D. W. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00273-9 · Cited by 27 · see citing works

In vivo models of hepatitis B and C virus infection

Winer, B. Y., Ding, Q., Gaska, J. M., & Ploß, A. (2016) · FEBS Letters · doi:10.1002/1873-3468.12157 · Cited by 26 · see citing works

Tandem mass spectrometric assay of succinylacetone in urine for the diagnosis of hepatorenal tyrosinemia

Rashed, M. S., Al-Ahaidib, L. Y., Al-Dirbashi, O. Y., Amoudi, M. A., Al‐Sayed, M., Rahbeeni, Z. A., Al‐Hassnan, Z. N., Al-Dbaas, A., Al‐Owain, M., & Luanaigh, M. N. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.01.014 · Cited by 26 · see citing works

Diurnal variation of phenylalanine concentrations in tyrosinaemia type 1: should we be concerned?

Daly, A., Gökmen-Özel, H., MacDonald, A., Preece, M. A., Davies, P. H. O., Chakrapani, A., & McKiernan, P. J. (2011) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2011.01215.x · Cited by 25 · see citing works

An engineered Escherichia coli Nissle strain prevents lethal liver injury in a mouse model of tyrosinemia type 1

Gu, P., Xie, L. X., Chen, T., Yang, Q. Z., Zhang, X., Liu, R., Guo, J., Wei, R., Li, D., Jiang, Y. Q., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.10.037 · Cited by 24 · see citing works

Nuclease-Mediated Gene Therapies for Inherited Metabolic Diseases of the Liver.

Te, B., Anglin, C. M., Bridges, P. H., & Cottle, R. N. (2017) · PubMed Central · Cited by 23 · see citing works

Chapter 33. To market, to market - 2002

Boyer-Joubert, C., Lorthiois, E., & Moreau, F. (2003) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(03)38034-0 · Cited by 23 · see citing works

Newborn screening for Tyr-I: Two years' experience of the New York State program

Morrissey, M. A., Sunny, S., Fahim, A., Lubowski, C., & Caggana, M. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.02.017 · Cited by 22 · see citing works

Hereditary tyrosinemia type 1 from a single center in Egypt: clinical study of 22 cases

El-Karaksy, H. M., Fahmy, M. E., El‐Raziky, M. S., El-Koofy, N. M., El‐Sayed, R., Rashed, M. S., El-Kiki, H., El-Hennawy, A., & Mohsen, N. (2011) · World Journal of Pediatrics · doi:10.1007/s12519-011-0287-3 · Cited by 21 · see citing works

Chronic Phenotype Characterization of a Large-Animal Model of Hereditary Tyrosinemia Type 1

Elgilani, F., Mao, S. A., Glorioso, J. M., Yin, M., Iankov, I. D., Singh, A., Amiot, B. P., Rinaldo, P., Marler, R. J., Ehman, R. L., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.09.013 · Cited by 20 · see citing works

Pregnancy in an NTBC‐Treated Patient With Hereditary Tyrosinemia Type I

Kassel, R., Sprietsma, L., & Rudnick, D. A. (2013) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3182a27463 · Cited by 18 · see citing works

Genetically blocking HPD via CRISPR-Cas9 protects against lethal liver injury in a pig model of tyrosinemia type I

Gu, P., Yang, Q. Z., Chen, B., Bie, Y., Liu, W., Tian, Y.-G., Luo, H., Xu, T., Liang, C., Ye, X., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.04.002 · Cited by 18 · see citing works

Effect of living donor liver transplantation on outcome of children with inherited liver disease and hepatocellular carcinoma

Özçay, F., Canan, O., Bilezikçi, B., Torgay, A., Karakayalı, H., & Haberal, M. A. (2006) · Clinical Transplantation · doi:10.1111/j.1399-0012.2006.00571.x · Cited by 18 · see citing works

Molecular changes associated with chronic liver damage and neoplastic lesions in a murine model of hereditary tyrosinemia type 1

Angileri, F., Roy, V., Morrow, G., Scoazec, J., Gadot, N., Orejuela, D., & Tanguay, R. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.002 · Cited by 17 · see citing works

In Vivo Selection of Transplanted Hepatocytes by Pharmacological Inhibition of Fumarylacetoacetate Hydrolase in Wild-type Mice

Paulk, N. K., Wursthorn, K., Haft, A., Pelz, C., Clarke, G. N., Newell, A. H., Olson, S. B., Harding, C. O., Finegold, M. J., Bateman, R. L., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.154 · Cited by 16 · see citing works

Liver transplantation for hepatocellular carcinoma in children

Sevmiş, Ş., Karakayalı, H., Özçay, F., Canan, O., Bilezikçi, B., Torgay, A., & Haberal, M. A. (2007) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00777.x · Cited by 17 · see citing works

Recapitulation of treatment response patterns in a novel humanized mouse model for chronic hepatitis B virus infection

Winer, B. Y., Huang, T., Low, B. E., Avery, C., Pais, M.-A., Hrebikova, G., Siu, E., Chiriboga, L. A., Wiles, M. V., & Ploß, A. (2016) · Virology · doi:10.1016/j.virol.2016.12.017 · Cited by 17 · see citing works

The future of gene-targeted therapy for hereditary tyrosinemia type 1 as a lead indication among the inborn errors of metabolism

Thompson, W. S., Mondal, G., VanLith, C. J., Kaiser, R. A., & Lillegard, J. B. (2020) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2020.1791082 · Cited by 14 · see citing works

High volume naked DNA tail‐vein injection restores liver function in Fah‐knock out mice

Eggenhofer, E., Doenecke, A., Renner, P., Slowik, P., Piso, P., Geissler, E. K., Schlitt, H. J., Dahlke, M. H., & Popp, F. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06156.x · Cited by 14 · see citing works

Experience with NTBC therapy in hereditary tyrosinaemia type I: an alternative to liver transplantation

Joshi, S. N., & Venugopalan, P. (2004) · Annals of Tropical Paediatrics · doi:10.1179/027249304225019000 · Cited by 13 · see citing works

Integrated Network Pharmacology Analysis and Serum Metabolomics to Reveal the Anti-malaria Mechanism of Artesunate

Wang, F., Jian, S., Yan, Y., Zhou, Q., Li, X., Wang, P., Yang, Z., Zhang, Q., & Zhang, H. (2022) · ACS Omega · doi:10.1021/acsomega.2c04157 · Cited by 11 · see citing works

Therapeutic hepatocyte transplant for inherited metabolic disorders: functional considerations, recent outcomes and future prospects

Vogel, K. R., Kennedy, A. A., Whitehouse, L. A., & Gibson, K. M. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-013-9656-5 · Cited by 10 · see citing works

Hepatotoxicity and Toxicology of In Vivo Lentiviral Vector Administration in Healthy and Liver-Injury Mouse Models

Kaiser, R. A., Nicolas, C. T., Allen, K. L., Chilton, J. A., Du, Z., Hickey, R., & Lillegard, J. B. (2019) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2018.249 · Cited by 10 · see citing works

Rescue from neonatal death in the murine model of hereditary tyrosinemia by glutathione monoethylester and vitamin C treatment

Langlois, C., Jorquera, R., Orejuela, D., Bergeron, A., Finegold, M. J., Rhead, W. J., & Tanguay, R. M. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.09.018 · Cited by 10 · see citing works

Heat Shock Response Associated with Hepatocarcinogenesis in a Murine Model of Hereditary Tyrosinemia Type I

Angileri, F., Morrow, G., Roy, V., Orejuela, D., & Tanguay, R. M. (2014) · Cancers · doi:10.3390/cancers6020998 · Cited by 10 · see citing works

Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype

Neuckermans, J., Lequeue, S., Claes, P., Heymans, A., Hughes, J. H., Colemonts‐Vroninks, H., Marcélis, L., Casimir, G. J., Goyens, P. J., Martens, G. A., et al. (2023) · Genes · doi:10.3390/genes14030693 · Cited by 9 · see citing works

Blood and Brain Biochemistry and Behaviour in NTBC and Dietary Treated Tyrosinemia Type 1 Mice

van Ginkel, W. G., van Vliet, D., van der Goot, E., van Faassen, M. H. J. R., Vogel, A., Heiner-Fokkema, M. R., van der Zee, E. A., & van Spronsen, F. J. (2019) · Nutrients · doi:10.3390/nu11102486 · Cited by 9 · see citing works

Amino Acid Metabolism

Wang, R., Wilcox, W. R., & Cederbaum, S. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00096-3 · Cited by 9 · see citing works

Impaired DNA repair and genomic stability in hereditary tyrosinemia type 1

van Dyk, E., & Pretorius, P. J. (2011) · Gene · doi:10.1016/j.gene.2011.12.021 · Cited by 8 · see citing works

Tyrosinemia type 1: an overview of nursing care.

Barnby, E. (2014) · PubMed · Cited by 8 · see citing works

Hepatocellular Carcinoma in Hereditary Tyrosinemia Type I Despite 2‐(2 Nitro‐4‐3 Trifluoro‐ Methylbenzoyl)‐1, 3‐Cyclohexanedione Treatment

van Spronsen, F. J., Bijleveld, C. M. A., van Maldegem, B. T., & Wijburg, F. A. (2005) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2005.tb00933.x · Cited by 8 · see citing works

La tyrosinémie héréditaire : une maladie du stress du réticulum endoplasmique ?

Bergeron, A., Jorquera, R., & Tanguay, R. M. (2003) · médecine/sciences · doi:10.1051/medsci/20031910976 · Cited by 7 · see citing works

Tissue-specific FAH deficiency alters sleep–wake patterns and results in chronic tyrosinemia in mice

Yang, S., Siepka, S. M., Cox, K. H., Kumar, V., de Groot, M. H. M., Chelliah, Y., Chen, J., Tu, B. P., & Takahashi, J. S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904485116 · Cited by 6 · see citing works

Fumarylacetoacetate hydrolase gene as a knockout target for hepatic chimerism and donor liver production

Larson, E. L., Joo, D. J., Nelson, E., Amiot, B. P., Aravalli, R. N., & Nyberg, S. L. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.09.018 · Cited by 6 · see citing works

Enhancing Newborn Screening for Tyrosinemia Type I

Pass, K. A., & Morrissey, M. A. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.103200 · Cited by 6 · see citing works

Hepatorenal Tyrosinemia

Tanguay, R. M., Bergeron, A., & Jorquera, R. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-449851-8.00040-1 · Cited by 5 · see citing works

Response to “Can ‘humanized’ mice improve drug development in the 21st century?”

Bissig, K., & Grompe, M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.06.001 · Cited by 5 · see citing works

Amino Acid Metabolism

Russo, R. S., & Wilcox, W. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-812535-9.00003-0 · Cited by 4 · see citing works

Biochemical and behavioural profile of NTBC treated Tyrosinemie type 1 mice

van Ginkel, W. G., Winn, S. R., Dudley, S., Krenik, D., Perez, R., Rimann, N., Thöny, B., Raber, J., & Harding, C. O. (2022) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2022.07.001 · Cited by 2 · see citing works

Primary Liver Cancer: Chemical Carcinogenesis

Thyparambil, S. P., Edmondson, R. D., & Dragan, Y. P. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-376-3_3 · Cited by 3 · see citing works

Chemically-Induced Hepatocarcinogenesis

Dragan, Y. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-34214-6_4 · Cited by 3 · see citing works

Liver Repopulation by Cell Transplantation and the Role of Stem Cells

Shafritz, D. A., Oertel, M., Dabeva, M. D., & Grompe, M. (2009) · Wiley eBooks · doi:10.1002/9780470747919.ch38 · Cited by 3 · see citing works

Tyrosinemia

Mitchell, G. A., Russo, P., Dubois, J., & Álvarez, F. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139012102.032 · Cited by 2 · see citing works

Attempts to Synthesize Fumarylacetoacetate Using the Filamentous Ascomycete, Aspergillus nidulans

Loughran, C. (2018) · doi:10.15760/honors.606 · Cited by 2 · see citing works

A 12-month, longitudinal, intervention study examining a tablet protein substitute preparation in the management of tyrosinemia

Daly, A., Evans, S., Pinto, A., Ashmore, C., & MacDonald, A. (2024) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2024.101119 · Cited by 1 · see citing works

An optimized engineered bacterium for tyrosinemia type 1 therapy: A multi-species preclinical study

Gu, P., Zhao, Y., Hu, J., Tian, Y., Zhao, L., Ren, J., Yang, Q., Li, J., He, W., Guo, J., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.05.024 · Cited by 1 · see citing works

Pharmacological and clinical profile of nitisinone (Orfadin® Capsules): a therapeutic agent for hereditary tyrosinemia type 1

Minoura, H., Iwai, M., Taniuchi, Y., Katashima, M., & Takahashi, H. (2015) · Folia Pharmacologica Japonica · doi:10.1254/fpj.146.342 · Cited by 1 · see citing works

Tyrosinemia type I as a model for studying epigenetic events in the aetiology of metabolic disease associated hepatocarcinoma

Gouws, C. (2011) · Boloka Institutional Repository (North-west University) · Cited by 1 · see citing works

A Case of Tyrosinemia Type 1 with Cytomegalovirus Infection

Cho, J. H., Shim, K. J., Kim, S. K., Shin, S. H., Lee, K. H., & Yun, H. S. (2004) · Korean Journal of Pediatrics · Cited by 1 · see citing works

Chromosomal integration in vitro and in vivo of high capacity adenoviral vectors

Stephen, S. L. (2007) · Kölner Universitäts PublikationsServer (Universität zu Köln)

Hepatic Progenitors in Development and Transplantation

Shafritz, D. A., Oertel, M., & Dabeva, M. D. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_16

une maladie du stress endoplasmique

Bergeron, A., Jorquera, R., & Tanguay, R. M. (2003)

Case Report Tyrosinemia Type 1: Clinical and Biochemical Analysis of Cases with Poor Treatment Outcome

Alobaidy, H., Yahya, N. A., & Said, R. M. (2011)

Novel strategies to improve viral gene targeting and therapeutic liver repopulation in vivo

Paulk, N. K. (2012) · doi:10.6083/m4k935jk

Tyrosinemia in Children

Mitchell, G. A., Russo, P., Dubois, J., Halac, U., & Álvarez, F. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108918978.031

Tyrosinemia

Mitchell, G. A., Russo, P., Dubois, J., & Álvarez, F. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511547409.031

NTBC dosing and outcomes in hereditary tyrosinemia type 1: insights from a representative human model and 99 patientsPreprint

Pham, Q. T., Tamnanloo, F., M’Callum, M.-A., Beaulieu, E., Mghabghab, R., Théorêt, Y., Mitchell, G. A., the Quebec NTBC Study Group, Cyr, D., Waters, P. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.06.680797

Therapeutic trials in the murine model of hereditary tyrosinaemia type I: A progress report

Grompe, M., Overturf, K., Al-Dhalimy, M., & Finegold, M. J. (1998) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005462804271 · Cited by 54 · see citing works

Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype

Neuckermans, J., Lequeue, S., Claes, P., Heymans, A., Hughes, J. H., Colemonts‐Vroninks, H., Marcélis, L., Casimir, G. J., Goyens, P. J., Martens, G. A., et al. (2023) · Genes · doi:10.3390/genes14030693 · Cited by 9 · see citing works

Évolution favorable sous traitement par NTBC de l'insuffisance hépatique aiguë révélatrice de la tyrosinémie héréditaire de type I

Barkaoui, E., Debray, D., Habès, D., de Baulny, H. O., & Bernard, O. (1999) · Archives de Pédiatrie · doi:10.1016/s0929-693x(99)80562-4 · Cited by 10 · see citing works

Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1

van Ginkel, W. G., Rodenburg, I. L., Harding, C. O., Hollak, C. E. M., Heiner-Fokkema, M. R., & van Spronsen, F. J. (2019) · Pediatric Drugs · doi:10.1007/s40272-019-00364-4 · Cited by 58 · see citing works

Hepatocellular Carcinoma in Hereditary Tyrosinemia Type I Despite 2-(2 Nitro-4-3 Trifluoro- Methylbenzoyl)-1, 3-Cyclohexanedione Treatment

van Spronsen, F. J., Bijleveld, C. M. A., van Maldegem, B. T., & Wijburg, F. A. (2005) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200501000-00017 · Cited by 92 · see citing works